Related Experiment Video
Updated: May 15, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Delivering cost-effective care for COPD in the USA: recent progress and current challenges
Ian M Breunig1, Fadia T Shaya, Steven M Scharf
1Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch Street, 12th floor, Room 01-209, Baltimore, MD 21201, USA. ibreunig@rx.umaryland.edu
Managing chronic obstructive pulmonary disease (COPD) requires balancing effective pharmacologic and nonpharmacologic therapies with patient resources and adherence. Establishing cost-effective treatment plans is crucial for reducing the economic burden of COPD.
Area of Science:
- Health Economics
- Pulmonology
- Pharmacoeconomics
Background:
- Chronic obstructive pulmonary disease (COPD) presents a substantial and increasing economic burden on the US healthcare system.
- Effective management of COPD is essential to mitigate healthcare costs associated with exacerbations.
Purpose of the Study:
- To review therapeutic management options for COPD, focusing on pharmacologic and nonpharmacologic strategies.
- To highlight the need for comprehensive, real-world economic evaluations in COPD treatment.
Main Methods:
- Exploration of existing reviews on COPD therapeutic management.
- Analysis of factors influencing treatment decisions, including resource availability, patient cost, response, and adherence.
Main Results:
- Both pharmacologic and nonpharmacologic therapies are beneficial for all COPD patients.
- Physician prescribing decisions are influenced by resource availability, patient cost, and adherence.
- A significant challenge remains in conducting comprehensive economic evaluations for COPD.
Conclusions:
- Integrating economic evaluations is vital for optimizing COPD care.
- Overcoming barriers to real-world economic assessments is necessary to establish cost-effective COPD management strategies.
- Tailoring therapy based on cost-effectiveness will improve patient outcomes and reduce healthcare expenditures.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
